Wilson lab part of multi-PI grant from NIAID to study cytomegalovirus control of host membrane trafficking (March 8, 2018)

Release Date: 
Mar 08, 2018

Dr. Jean Wilson of Cellular & Molecular Medicine and Dr. Felicia Goodrum of Immunobiology have secured a 5 year grant from the National Institute of Allergy and Infectious Disease.  This $1.9M grant is entitled “Cytomegalovirus Control of Host Membrane Trafficking.” Cytomegalovirus is a major cause of birth defects and increases risk for vascular disease and other age-related pathologies. These funds will be used to study how the virus co-opts host cell membrane trafficking to promote its survival and replication.